US2015225690A1PendingUtilityA1

Yeast mutant and yeast extract

43
Assignee: KOHJIN COPriority: Mar 31, 2008Filed: Apr 23, 2015Published: Aug 13, 2015
Est. expiryMar 31, 2028(~1.7 yrs left)· nominal 20-yr term from priority
C12N 15/01C12P 13/14A23L 27/10A23V 2002/00A23L 31/15A23L 33/145C12P 19/32C12N 1/16A23L 33/14C12R 2001/72C12N 1/165
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A natural yeast extract which is rich in glutamic acid and therefore has an impact at first taste. Further, provided is a yeast extract which is also rich in 5′-guanylic acid or 5′-inosinic acid and therefore has strong umami. Further, provided is a yeast mutant capable of accumulating a large amount of glutamic acid, glutamine and ribonucleic acid for obtaining such a yeast extract. A yeast mutant to which resistance to organic acids and analogues thereof has been imparted by inducing spontaneous mutation, accumulates a significant amount, i.e., 10% by weight or more of the total of free glutamic acid and glutamine in the cell, and further accumulates 5% by weight or more of a ribonucleic acid. The yeast extract produced by using this strain contains 20% by weight or more of L-glutamic acid, and further contains 3% by weight or more of 5′-IG.

Claims

exact text as granted — not AI-modified
1 . A yeast mutant, wherein free glutamic acid and glutamine are accumulated in a total amount of 10% or more, based on a weight of a dry cell. 
     
     
         2 . The yeast mutant according to  claim 1 , wherein ribonucleic acid (RNA) is further accumulated in an amount of 5% or more, based on a weight of a dry cell. 
     
     
         3 . The yeast mutant according to  claim 1 , wherein the yeast mutant is tolerant to ethyl bromopyruvate. 
     
     
         4 . The yeast mutant according to  claim 1 , wherein the yeast mutant is tolerant to ethyl bromopyruvate and 2-oxoglutaric acid. 
     
     
         5 . The yeast mutant according to  claim 1 , wherein the yeast mutant is  Candida utilis  36D61 (accession number: FERM BP-11103). 
     
     
         6 . A yeast extract produced from the yeast mutant as claimed in  claim 1 , wherein the yeast extract contains L-glutamic acid in an amount of 20% by weight or more converted into an amount of a sodium salt thereof. 
     
     
         7 . The yeast extract according to  claim 6 , wherein the yeast extract further contains 5′-guanylic acid and 5′-inosinic acid or 5′-adenylic acid in a total amount of 3% by weight or more.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.